Skip to main content
# Title Department Research Member Research Year
91 FOXP3 Expression as a Biomarker in Metastatic Colorectal Cancer Treated with Irinotecan-based Therapy Department of Medical Oncology Dr. Amen Hamdy Zaki Ali 2023
92 FOXP3 Expression as a Biomarker in Metastatic Colorectal Cancer Treated with Irinotecan-based Therapy Department of Medical Oncology Dr. Shimaa Hassan Shabaan Hassan 2023
93 Surgical Outcomes of Laparoscopic-assisted Distal Gastrectomy Versus Totally Laparoscopic Distal Gastrectomy Billroth I for Gastric Cancer Department of Surgical Oncology Prof. Doaa Wadie Maximous Dawoud 2023
94 Surgical Outcomes of Laparoscopic-assisted Distal Gastrectomy Versus Totally Laparoscopic Distal Gastrectomy Billroth I for Gastric Cancer Department of Surgical Oncology Ahmed Hamdy Motamiez Ibrahim 2023
95 Noncompliance of pediatric cancer patients with chemotherapy: A single-center experience in a lower-middle income country Department of Pediatric Oncology Ahmed Abdelwahab Faraag Mohammed 2023
96 Could Local Surgery Improve Survival in Stage IV Breast Cancer? Department of Surgical Oncology Dr. Ahmed Refaat Abdel Zaher Mubarak 2023
97 CD44 as a prognostic marker in early colorectal cancer: single center experience “South Egypt cancer institute”, Egypt Department of Medical Oncology Amany Nasr Ahmed Mohammed Elemary 2023
98 Value of FoxO3a Gene Expression in Pediatric Acute Lymphoblastic Leukemia Department of Clinical Pathology Madonna Refaat Ayoub 2023
99 Visceral and Subcutaneous Fat, Muscle Mass, and Liver Volume as Non-invasive Predictors of the Progress of Non-alcoholic Fatty Liver Disease Department of Radiology Dr. Omar Mustafa Mahmoud Mohamed 2023
100 Effective and Elaborative Induction Program for Mitigating Myths and Misconceptions Linked to Hematopoietic Stem Cell Transplantation in a Resource Limited Setting Department of Pediatric Oncology Mahmoud Motaz Elzembely 2023